Reversible dementia associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis in ANCA-associated vasculitis

Microscopic polyangiitis (MPA) is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a small-vessel vasculitis that can cause organ-threatening complications. Hypertrophic pachymeningitis is a rare, central nervous system manifestation of AAV rarely involving the spine. We herein report a patient with myeloperoxidase-ANCA-positive MPA presenting with progressive cognitive decline and gait disturbance associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis. The patient responded well to high-dose prednisolone and rituximab and showed significant clinical and radiological improvement without surgery. The present case not only demonstrated that spinal hypertrophic pachymeningitis in AAV can cause reversible dementia associated with communicating hydrocephalus but also highlighted the potential of timely immunosuppressive therapy to induce remission.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2025-01-01
DOI
https://doi.org/10.1093/mrcr/rxaf051
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reversible dementia associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis in ANCA-associated vasculitis

Yuki Terashima, Naoto Yokogawa, Yoshitaka Ueda
Modern Rheumatology Case Reports
Vasculitis and related conditions
article

Reversible dementia associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis in ANCA-associated vasculitis

Yuki Terashima, Naoto Yokogawa, Yoshitaka Ueda
article en

Abstract

Microscopic polyangiitis (MPA) is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a small-vessel vasculitis that can cause organ-threatening complications. Hypertrophic pachymeningitis is a rare, central nervous system manifestation of AAV rarely involving the spine. We herein report a patient with myeloperoxidase-ANCA-positive MPA presenting with progressive cognitive decline and gait disturbance associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis. The patient responded well to high-dose prednisolone and rituximab and showed significant clinical and radiological improvement without surgery. The present case not only demonstrated that spinal hypertrophic pachymeningitis in AAV can cause reversible dementia associated with communicating hydrocephalus but also highlighted the potential of timely immunosuppressive therapy to induce remission.

Modern Rheumatology Case ReportsVol. 9(2)
Tokyo Metropolitan Tama Medical Center (JP)
Openalex Percentile: Top 70%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.